Tofogliflozin

DB11824InvestigationalSmall molecule

Tofogliflozin has been used in trials studying the treatment and prevention of Diabetes Mellitus Type 2.

Chemical structure of Tofogliflozin
Mechanism
Curator reviewed
Formula / weight
C22H26O6 · 386.444 g/mol (avg)
Code names
CSG-452 · R-7201 · RO-4998452

Resolves to

Compound
UNII554245W62TCAS903565-83-3ChEMBLCHEMBL2110731ChEBI136041PubChem46908929
Structure
InChIKeyVWVKUNOPTJGDOB-BDHVOXNPSA-NSMILESCCC1=CC=C(CC2=CC=C3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=C2)C=C1
Targets
P31639SLC5A2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
609Drug interactionsStructured to mechanism, not free text
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tofogliflozin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In